You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Uterine Fibroid Embolization Agents Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

The global Uterine Fibroid Embolization Agents market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Uterine Fibroid Embolization Agents by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Gelatin Sponge
Polyvinyl Alcohol (PVA) Particles
Trisacryl Gelatin Microspheres (TAGM)
Polymethyl Methacrylate (PMMA) Microspheres
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Astellas Pharma
Nippon Kayaku
Pfizer
Boston Scientific Corporation
Merit Medical Systems,Inc.
Cook Medical

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Clinical Research Institutes
Hospital
Surgical Centers
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
Table of Contents
1 Industry Overview
1.1 Uterine Fibroid Embolization Agents Industry
Figure Uterine Fibroid Embolization Agents Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Uterine Fibroid Embolization Agents
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Uterine Fibroid Embolization Agents
1.2.2 Downstream
Table Application Segment of Uterine Fibroid Embolization Agents
Table Global Uterine Fibroid Embolization Agents Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Uterine Fibroid Embolization Agents Market by Type
3.1 By Type
3.1.1 Gelatin Sponge
Table Major Company List of Gelatin Sponge
3.1.2 Polyvinyl Alcohol (PVA) Particles
Table Major Company List of Polyvinyl Alcohol (PVA) Particles
3.1.3 Trisacryl Gelatin Microspheres (TAGM)
Table Major Company List of Trisacryl Gelatin Microspheres (TAGM)
3.1.4 Polymethyl Methacrylate (PMMA) Microspheres
Table Major Company List of Polymethyl Methacrylate (PMMA) Microspheres
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Uterine Fibroid Embolization Agents Market 2016-2020, by Type, in USD Million
Figure Global Uterine Fibroid Embolization Agents Market Growth 2016-2020, by Type, in USD Million
Table Global Uterine Fibroid Embolization Agents Market 2016-2020, by Type, in Volume
Figure Global Uterine Fibroid Embolization Agents Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Uterine Fibroid Embolization Agents Market Forecast 2021-2026, by Type, in USD Million
Table Global Uterine Fibroid Embolization Agents Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Astellas Pharma (Company Profile, Sales Data etc.)
4.1.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
4.1.2 Astellas Pharma Products & Services
4.1.3 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Nippon Kayaku (Company Profile, Sales Data etc.)
4.2.1 Nippon Kayaku Profile
Table Nippon Kayaku Overview List
4.2.2 Nippon Kayaku Products & Services
4.2.3 Nippon Kayaku Business Operation Conditions
Table Business Operation of Nippon Kayaku (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Pfizer (Company Profile, Sales Data etc.)
4.3.1 Pfizer Profile
Table Pfizer Overview List
4.3.2 Pfizer Products & Services
4.3.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Boston Scientific Corporation (Company Profile, Sales Data etc.)
4.4.1 Boston Scientific Corporation Profile
Table Boston Scientific Corporation Overview List
4.4.2 Boston Scientific Corporation Products & Services
4.4.3 Boston Scientific Corporation Business Operation Conditions
Table Business Operation of Boston Scientific Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Merit Medical Systems,Inc. (Company Profile, Sales Data etc.)
4.5.1 Merit Medical Systems,Inc. Profile
Table Merit Medical Systems,Inc. Overview List
4.5.2 Merit Medical Systems,Inc. Products & Services
4.5.3 Merit Medical Systems,Inc. Business Operation Conditions
Table Business Operation of Merit Medical Systems,Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Cook Medical (Company Profile, Sales Data etc.)
4.6.1 Cook Medical Profile
Table Cook Medical Overview List
4.6.2 Cook Medical Products & Services
4.6.3 Cook Medical Business Operation Conditions
Table Business Operation of Cook Medical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Uterine Fibroid Embolization Agents Sales Revenue 2016-2020, by Company, in USD Million
Table Global Uterine Fibroid Embolization Agents Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Uterine Fibroid Embolization Agents Sales Revenue Share in 2020, by Company, in USD Million
Table Global Uterine Fibroid Embolization Agents Sales Volume 2016-2020, by Company, in Volume
Table Global Uterine Fibroid Embolization Agents Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Uterine Fibroid Embolization Agents Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Uterine Fibroid Embolization Agents Market Concentration, in 2020
Figure Europe Uterine Fibroid Embolization Agents Market Market Concentration, in 2020
Figure Asia-Pacific Uterine Fibroid Embolization Agents MMarket Concentration, in 2020
Figure South America Uterine Fibroid Embolization Agents Market Concentration, in 2020
Figure Middle East & Africa Uterine Fibroid Embolization Agents Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Clinical Research Institutes
Figure Uterine Fibroid Embolization Agents Demand in Clinical Research Institutes, 2016-2020, in USD Million
Figure Uterine Fibroid Embolization Agents Demand in Clinical Research Institutes, 2016-2020, in Volume
6.1.2 Demand in Hospital
Figure Uterine Fibroid Embolization Agents Demand in Hospital, 2016-2020, in USD Million
Figure Uterine Fibroid Embolization Agents Demand in Hospital, 2016-2020, in Volume
6.1.3 Demand in Surgical Centers
Figure Uterine Fibroid Embolization Agents Demand in Surgical Centers, 2016-2020, in USD Million
Figure Uterine Fibroid Embolization Agents Demand in Surgical Centers, 2016-2020, in Volume
6.1.4 Demand in Others
Figure Uterine Fibroid Embolization Agents Demand in Others, 2016-2020, in USD Million
Figure Uterine Fibroid Embolization Agents Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Uterine Fibroid Embolization Agents Demand Forecast 2021-2026, by Application, in USD Million
Figure Uterine Fibroid Embolization Agents Market Growth 2021-2026, by Application, in USD Million
Figure Uterine Fibroid Embolization Agents Market Share in 2026, by Application, in USD Million
Table Uterine Fibroid Embolization Agents Demand Forecast 2021-2026, by Application, in Volume
Table Uterine Fibroid Embolization Agents Market Growth 2021-2026, by Application, in Volume
Table Uterine Fibroid Embolization Agents Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Uterine Fibroid Embolization Agents Production 2016-2020, by Region, in USD Million
Table Uterine Fibroid Embolization Agents Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Uterine Fibroid Embolization Agents Market 2016-2020, by Region, in USD Million
Table Global Uterine Fibroid Embolization Agents Market Share 2016-2020, by Region, in USD Million
Table Global Uterine Fibroid Embolization Agents Market 2016-2020, by Region, in Volume
Table Global Uterine Fibroid Embolization Agents Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Uterine Fibroid Embolization Agents Market Size and Growth 2016-2020, in USD Million
Figure North America Uterine Fibroid Embolization Agents Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Uterine Fibroid Embolization Agents Market Size 2016-2020, by Country, in USD Million
Table North America Uterine Fibroid Embolization Agents Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Uterine Fibroid Embolization Agents Market Size and Growth 2016-2020, in USD Million
Figure Europe Uterine Fibroid Embolization Agents Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Uterine Fibroid Embolization Agents Market Size 2016-2020, by Country, in USD Million
Table Europe Uterine Fibroid Embolization Agents Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Uterine Fibroid Embolization Agents Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Uterine Fibroid Embolization Agents Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Uterine Fibroid Embolization Agents Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Uterine Fibroid Embolization Agents Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Uterine Fibroid Embolization Agents Market Size and Growth 2016-2020, in USD Million
Figure South America Uterine Fibroid Embolization Agents Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Uterine Fibroid Embolization Agents Market Size 2016-2020, by Country, in USD Million
Table South America Uterine Fibroid Embolization Agents Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Uterine Fibroid Embolization Agents Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Uterine Fibroid Embolization Agents Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Uterine Fibroid Embolization Agents Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Uterine Fibroid Embolization Agents Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Uterine Fibroid Embolization Agents Market Forecast 2021-2026, by Region, in USD Million
Table Uterine Fibroid Embolization Agents Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: May, 2021
  • NO OF PAGES: 91